Restoring Multidrug-Resistant Escherichia coli Sensitivity to Ampicillin in Combination with (−)-Epigallocatechin Gallate
Authors:
- Anong KiddeeAKAnong Kiddee
- Atchariya YosboonruangAYAtchariya Yosboonruang
- Achiraya SiriphapASAchiraya Siriphap
- Grissana Pook-InGPGrissana Pook-In
- Chittakun SuwancharoenCSChittakun Suwancharoen
- Acharaporn DuangjaiADAcharaporn Duangjai
- Ratsada PraphasawatRPRatsada Praphasawat
- Masami SuganumaMSMasami Suganuma
- Anchalee RawangkanARAnchalee Rawangkan
Open Access
- 13 December 2024
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 13 (12) , 1211
Abstract
Multidrug-resistant (MDR) bacteria, especially Escherichia coli, are a major contributor to healthcare-associated infections globally, posing significant treatment challenges. This study explores the efficacy of (−)-epigallocatechin gallate (EGCG), a natural constituent of green tea, in combination with ampicillin (AMP) to restore the effectiveness of AMP against 40 isolated MDR E. coli strains. Antimicrobial activity assays were conducted to determine the minimum inhibitory concentrations (MIC) of EGCG using the standard microdilution technique. Checkerboard assays were employed to assess the potential synergistic effects of EGCG combined with AMP. The pharmacodynamic effects of the combination were evaluated through time-kill assays. Outer membrane disruption was analyzed by measuring DNA and protein leakage and with assessments using N-phenyl-1-naphthylamine (NPN) and rhodamine 123 (Rh123) fluorescence dyes. Biofilm eradication studies involved biofilm formation assays and preformed biofilm biomass and viability assays. Scanning electron microscopy (SEM) was used to examine changes in cellular morphology. The results indicated that EGCG demonstrated activity against all isolates, with MICs ranging from 0.5 to 2 mg/mL, while AMP exhibited MIC values between 1.25 and 50 mg/mL. Importantly, the EGCG-AMP combination showed enhanced efficacy compared to either treatment alone, as indicated by a fractional inhibitory concentration index between 0.009 and 0.018. The most pronounced synergy was observed in 13 drug-resistant strains, where the MIC for EGCG dropped to 8 µg/mL (from 1 mg/mL alone) and that for AMP to 50 µg/mL (from 50 mg/mL alone), achieving a 125-fold and 1000-fold reduction, respectively. Time-kill assays revealed that the bactericidal effect of the EGCG-AMP combination occurred within 2 h. The mechanism of EGCG action includes the disruption of membrane permeability and biofilm eradication in a dose-dependent manner. SEM confirmed that the combination treatment consistently outperformed the individual treatments. This study underscores the potential of restoring AMP efficacy in combination with EGCG as a promising strategy for treating MDR E. coli infections.Keywords
Funding Information
- University of Phayao and Thailand Science Research and Innovation Fund (5031/2567, 5136/2567, MS 241004)
- School of Medical Sciences, University of Phayao (5031/2567, 5136/2567, MS 241004)
This publication has 50 references indexed in Scilit:
- Pharmacokinetic-Pharmacodynamic Study of Ampicillin-Cloxacillin Combination in Indian Thoroughbred Horses (Equus caballus) and Safety Evaluation of the Computed Dosage RegimenJournal of Equine Veterinary Science, 2022
- Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature reviewIDCases, 2022
- Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infectionsInternal and Emergency Medicine, 2021
- Effect of epigallocatechin gallate on gene expression of Staphylococcus aureusJournal of Global Antimicrobial Resistance, 2020
- Biofilm inhibition and mode of action of epigallocatechin gallate against Vibrio mimicusFood Control, 2020
- Antibacterial activities of green tea crude extracts and synergistic effects of epigallocatechingallate (EGCG) with gentamicin against MDR pathogensHeliyon, 2019
- Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactantsBiotechnology Letters, 2016
- Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applicationsBiochemical Pharmacology, 2011
- In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton brothDiagnostic Microbiology and Infectious Disease, 2007
- Bactericidal catechins damage the lipid bilayerBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993